PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice ; volume:15 ; number:9 ; day:25 ; month:7 ; year:2024 ; pages:2079-2095 ; date:9.2024
Diabetes therapy ; 15, Heft 9 (25.7.2024), 2079-2095, 9.2024

Creator
Catrina, Sergiu-Bogdan
Amadid, Hanan
Braae, Uffe C.
Dereke, Jonatan
Ekberg, Neda Rajamand
Klanger, Boris
Jansson, Stefan
Contributor
SpringerLink (Online service)

DOI
10.1007/s13300-024-01614-6
URN
urn:nbn:de:101:1-2411042119390.975428671062
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Catrina, Sergiu-Bogdan
  • Amadid, Hanan
  • Braae, Uffe C.
  • Dereke, Jonatan
  • Ekberg, Neda Rajamand
  • Klanger, Boris
  • Jansson, Stefan
  • SpringerLink (Online service)

Other Objects (12)

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study

PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes

PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes

Semaglutide treatment of hypothalamic obesity – a real-life data study

Semaglutide treatment of hypothalamic obesity – a real-life data study

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study

Semaglutide

Semaglutide

Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study

Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study

Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany

Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany

Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population

Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population

Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide

Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide

Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients

Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients

Pioneer

Plakat

Pioneer

Related objects